Contracts and Contract Negotiations

12 April 2023

RA Patients on Biologics and tsDMARDs are still High Risk

A new Swedish ARTIS registry study of key safety outcomes in rheumatoid arthritis (RA) patients receiving either targeted synthetic or biological disease-modifying antirheumatic drugs (b/ts DMARDs, including Janus Kinase inhibitors (JAKi)), has been updated and affirms previously held risks.

This 11-year study included 20 117 RA patients (~35 000 b/tsDMARD initiations) to look at select key safety outcomes while adjusting for potential confounders.

12 April 2023

Best Treatments for Immune Checkpoint Inhibitor-associated Arthritis

A retrospective study of cancer patients who developed immune checkpoint inhibitor-associated inflammatory arthritis (ICI-IA) shows that biologic DMARDs were more effective than conventional synthetic DMARDs (csDMARDs) in rapid control of arthritis.

Rheumatologist - Work-Life Survey Results Last week, registered Rheumatologists responded to an email survey regarding

Tweet Author

RheumNow

Tweet Content

Rheumatologist - Work-Life Survey Results Last week, registered Rheumatologists responded to an email survey regarding work-life balance. The following are the results from 190 respondents - 53% were male (47% female) and 94% were from the USA. https://t.co/2g7oL6ltAo https://t.co/uYv7sDyO9o

Links

https://bit.ly/3mtFhZA

Dr. Megan Clowse discusses the differences in pregnancy planning for men and women with rheumatic disease, with particul

Tweet Author

RheumNow

Tweet Content

Dr. Megan Clowse discusses the differences in pregnancy planning for men and women with rheumatic disease, with particular focus on medication use. Watch now. https://t.co/Ine8CdbZR4 https://t.co/7UnanlnQcC

Links

https://bit.ly/3Kod7r1

FDA FAERS study of IL-17 inhib & colitis: 388 pts w/ suspected IL-17i assoc. IBD. Median age - 42 yrs; Initial Sxs=

Tweet Author

RheumNow

Tweet Content

FDA FAERS study of IL-17 inhib & colitis: 388 pts w/ suspected IL-17i assoc. IBD. Median age - 42 yrs; Initial Sxs= diarrhea 91%, Abd pain 58%, bloody diarrhea 51%), & fever 36%, ^WBC 87%; Time to onset=2.9 mos. Time to remission after IL-17i D/C =4 wks https://t.co/adrtUhFj9C https://t.co/61GC5hvzYV

Links

https://bit.ly/40Vfokr

Retrospective study of 42 pts w/ cocaine-induced midline or systemic vasculitis; Current cocaine use common (20/23 + uri

Tweet Author

RheumNow

Tweet Content

Retrospective study of 42 pts w/ cocaine-induced midline or systemic vasculitis; Current cocaine use common (20/23 + urine tox, including pts who prev. deniedcocaine). Found: septal perfs (75%), oronasal fistula(15%), less(27%) systemic Sxs, 56% PR3-ANCA+https://t.co/z1Z4INRSj5 https://t.co/v9ZyZD1Lrb

Links

https://bit.ly/40VEH67

With AI and GPT-4... "The cognitive speed limit has just been lifted." - John Nosta https://t.co/mMXos8LLt6 https://t

Tweet Author

RheumNow

Tweet Content

With AI and GPT-4... "The cognitive speed limit has just been lifted." - John Nosta https://t.co/mMXos8LLt6 https://t.co/imBfp37J1l

Links

https://bit.ly/3UtS4Ii

Spanish Society of Rheumatology (SER) study finds w/ retirement of many older (male) Rheums; there are workforce shortag

Tweet Author

RheumNow

Tweet Content

Spanish Society of Rheumatology (SER) study finds w/ retirement of many older (male) Rheums; there are workforce shortages. Most (59.7%) of rheums in Spain are women, the majority below age 54 yrs. https://t.co/DPs0S63Aqc https://t.co/ig4kOQWmkn

Links

https://bit.ly/415gqds

vit D shows no change in Fx Risk. Study of 20,326 Australians given placebo or vit D3 60K IU/mo. 46% women, age 69 yrs.

Tweet Author

RheumNow

Tweet Content

vit D shows no change in Fx Risk. Study of 20,326 Australians given placebo or vit D3 60K IU/mo. 46% women, age 69 yrs. W/ 5.1 yrs F/U - no effect on Fx risk (HR 0·94; 0·84–1·06). Fx in 5.6% of Vit D vs 5.9% in PBO (non-vertebral, major OP & hip Fxs https://t.co/cSbTS3xWrX https://t.co/Jipzw28Wn8

Links

https://bit.ly/3mcMygA

Topics

Contracts and Contract Negotiations

Rheumatologist - Work-Life Survey Results Last week, registered Rheumatologists responded to an email survey regarding

Dr. Megan Clowse discusses the differences in pregnancy planning for men and women with rheumatic disease, with particul

FDA FAERS study of IL-17 inhib & colitis: 388 pts w/ suspected IL-17i assoc. IBD. Median age - 42 yrs; Initial Sxs=

Retrospective study of 42 pts w/ cocaine-induced midline or systemic vasculitis; Current cocaine use common (20/23 + uri

With AI and GPT-4... "The cognitive speed limit has just been lifted." - John Nosta https://t.co/mMXos8LLt6 https://t

Spanish Society of Rheumatology (SER) study finds w/ retirement of many older (male) Rheums; there are workforce shortag

vit D shows no change in Fx Risk. Study of 20,326 Australians given placebo or vit D3 60K IU/mo. 46% women, age 69 yrs.

Do you get our email newsletter?

Contracts and Contract Negotiations

Rheumatologist - Work-Life Survey Results Last week, registered Rheumatologists responded to an email survey regarding

Dr. Megan Clowse discusses the differences in pregnancy planning for men and women with rheumatic disease, with particul

FDA FAERS study of IL-17 inhib &amp; colitis: 388 pts w/ suspected IL-17i assoc. IBD. Median age - 42 yrs; Initial Sxs=

Retrospective study of 42 pts w/ cocaine-induced midline or systemic vasculitis; Current cocaine use common (20/23 + uri

With AI and GPT-4... "The cognitive speed limit has just been lifted." - John Nosta https://t.co/mMXos8LLt6 https://t

Spanish Society of Rheumatology (SER) study finds w/ retirement of many older (male) Rheums; there are workforce shortag

vit D shows no change in Fx Risk. Study of 20,326 Australians given placebo or vit D3 60K IU/mo. 46% women, age 69 yrs.

FDA FAERS study of IL-17 inhib & colitis: 388 pts w/ suspected IL-17i assoc. IBD. Median age - 42 yrs; Initial Sxs=